Company Overview

ONCODE Scientific Sdn Bhd was founded in 2015, by a strong knowledge-based management and technical team with a combination of more than 85 years experience in the areas of medical diagnostics and clinical research. Oncode is a niche player specializing in Precision Medicine utilizing the techniques of Next Generation Sequencing (NGS), Sanger sequencing, fragment analysis, Real-Time & Standard PCR technologies and many other molecular technologies. The team comprises of scientists, pathologists, geneticists, clinicians, pharmacists, bioinformaticians and business veterans who aim to deliver the best quality of affordable molecular diagnostic solutions to the global community. 

Oncode laboratory workflows & pipelines include internal & external validations and quality controls in compliance with numerous international guidelines and standards such as Good Laboratory Practice (GLP), ISO 15189, the Association for Molecular Pathology (AMP) and the College of American Pathologist (CAP). The laboratory participates in external quality assurance and proficiency programs including the UK National External Quality Assurance System (UKNEQAS), the European Molecular Genetics Quality Network (EMQN) and the Royal College of Pathologists of Australasia (RCPA).